Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Armbruster

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Laboratory|April 24, 2007
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schöndorf, Thomas Forst, Cloth Hohberg, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 2007
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitusThomas Schöndorf, Georg Lübben, Markus Hoopmann, et al.
International Journal of Bioprinting|September 15, 2022
Bone Sialoprotein Immobilized in Collagen Type I Enhances Bone Regeneration In vitro and In vivoAnja Kriegel, Christian Schlosser, Tanja Habeck, et al.
Kidney & Blood Pressure Research|August 7, 2019
Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of DiseaseThomas Bernd Dschietzig, Karl-Heinz Kellner, Katrin Sasse, et al.
Polymers|February 28, 2023
Bone Sialoprotein Immobilized in Collagen Type I Enhances Angiogenesis In Vitro and In OvoAnja Kriegel, Eva Langendorf, Valentina Kottmann, et al.
Regulatory Peptides|December 7, 2002
Plasma levels and cardiovascular gene expression of urotensin-II in human heart failureThomas Dschietzig, Cornelia Bartsch, Rainer Pregla, et al.
Kidney & Blood Pressure Research|March 21, 2015
Relaxin-2 does not ameliorate nephropathy in an experimental model of type-1 diabetesThomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, et al.
RMD Open|April 25, 2024
Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosisNadine Zehrfeld, Malin Abelmann, Sabrina Benz, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Laboratory|April 24, 2007
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schöndorf, Thomas Forst, Cloth Hohberg, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 2007
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitusThomas Schöndorf, Georg Lübben, Markus Hoopmann, et al.
International Journal of Bioprinting|September 15, 2022
Bone Sialoprotein Immobilized in Collagen Type I Enhances Bone Regeneration In vitro and In vivoAnja Kriegel, Christian Schlosser, Tanja Habeck, et al.
Kidney & Blood Pressure Research|August 7, 2019
Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of DiseaseThomas Bernd Dschietzig, Karl-Heinz Kellner, Katrin Sasse, et al.
Polymers|February 28, 2023
Bone Sialoprotein Immobilized in Collagen Type I Enhances Angiogenesis In Vitro and In OvoAnja Kriegel, Eva Langendorf, Valentina Kottmann, et al.
Regulatory Peptides|December 7, 2002
Plasma levels and cardiovascular gene expression of urotensin-II in human heart failureThomas Dschietzig, Cornelia Bartsch, Rainer Pregla, et al.
Kidney & Blood Pressure Research|March 21, 2015
Relaxin-2 does not ameliorate nephropathy in an experimental model of type-1 diabetesThomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, et al.
RMD Open|April 25, 2024
Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosisNadine Zehrfeld, Malin Abelmann, Sabrina Benz, et al.
Pageof 5